311 related articles for article (PubMed ID: 21997907)
1. Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.
Pemmer B; Hofstaetter JG; Meirer F; Smolek S; Wobrauschek P; Simon R; Fuchs RK; Allen MR; Condon KW; Reinwald S; Phipps RJ; Burr DB; Paschalis EP; Klaushofer K; Streli C; Roschger P
J Synchrotron Radiat; 2011 Nov; 18(Pt 6):835-41. PubMed ID: 21997907
[TBL] [Abstract][Full Text] [Related]
2. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.
Roschger P; Manjubala I; Zoeger N; Meirer F; Simon R; Li C; Fratzl-Zelman N; Misof BM; Paschalis EP; Streli C; Fratzl P; Klaushofer K
J Bone Miner Res; 2010 Apr; 25(4):891-900. PubMed ID: 20437609
[TBL] [Abstract][Full Text] [Related]
3. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
[TBL] [Abstract][Full Text] [Related]
5. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
[TBL] [Abstract][Full Text] [Related]
6. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
7. Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate.
Oliveira JP; Querido W; Caldas RJ; Campos AP; Abraçado LG; Farina M
Calcif Tissue Int; 2012 Sep; 91(3):186-95. PubMed ID: 22806682
[TBL] [Abstract][Full Text] [Related]
8. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term treatment with strontium ranelate on bone strontium content.
Bärenholdt O; Kolthoff N; Nielsen SP
Bone; 2009 Aug; 45(2):200-6. PubMed ID: 19376283
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
12. Compositional and material properties of rat bone after bisphosphonate and/or Strontium ranelate drug treatment.
Wu Y; Adeeb SM; Duke MJ; Munoz-Paniagua D; Doschak MR
J Pharm Pharm Sci; 2013; 16(1):52-64. PubMed ID: 23683605
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
Seeman E
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
15. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
[TBL] [Abstract][Full Text] [Related]
16. Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism.
Carnevale V; Del Fiacco R; Romagnoli E; Fontana A; Cipriani C; Pepe J; Minisola S
Calcif Tissue Int; 2013 Jan; 92(1):15-22. PubMed ID: 23080188
[TBL] [Abstract][Full Text] [Related]
17. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
19. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
[TBL] [Abstract][Full Text] [Related]
20. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
